Growth and factors affecting it in thalassemia major

Hemoglobin

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Soliman, Ashraf T ^a   Khalafallah, Hany ^a   Ashour, Rasha ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Constitutional delay of growth and puberty (CDGP); GH deficiency (GHD); Growth Hormone (GH); IGF I; Nutrition

Indexed keywords

CALCIUM; CHORIONIC GONADOTROPIN; CLONIDINE; DEFEROXAMINE; GLUCAGON; GROWTH FACTOR; GROWTH HORMONE; INTERLEUKIN 1BETA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADOLESCENT; ADULT; ARM CIRCUMFERENCE; CHILD; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FRACTURE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HUMAN; HYPOCALCEMIA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PROVOCATION; PROVOCATION TEST; SCHOOL CHILD; SKINFOLD THICKNESS; THALASSEMIA MAJOR; VITAMIN SUPPLEMENTATION;

ADOLESCENT; BETA-THALASSEMIA; BODY SIZE; CHILD; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; SKINFOLD THICKNESS;

EID: 73949087911     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903347781     Document Type: Conference Paper

References (38)

1. Anita S. Growth retardation in thalassemia major patients. Int J Hum Genet. 2003;3(4):237-246.
2. Soliman AT, ElZalabany MM, Amer M, Ansari BM. Growth and pubertal development in transfusiondependent children and adolescents with thalassaemia major and sickle cell disease: A comparative study. J Trop Pediatr. 1999;45(1):23-30.
3. Karlberg J, Jalil F, Lam B, Low L, et al.. Linear growth retardation in relation to the three phases of growth. In: John C. Waterlow, Bent Schürch, eds. Causes and Mechanisms of Linear Growth Retardation. Proceedings of an I/D/E/G/C Workshop held in London, U.K, January 15-18, 1993. Eur J Clin Nutr. 1993.
4. Soliman AT. Study of growth and bone mineral density and factors affecting them in children and adolescents with thalassaemia major and sickle cell disease. PhD thesis, The University of Glamorgan, Glamorgan, UK, 1998.
5. Soliman AT, El-Matary W, Fattah MM, et al. The effect of high-calorie diet on nutritional parameters of children with b-thalassaemia major. Clin Nutr. 2004;23(5):1153-1158.
6. Soliman AT, El Banna N, Ansari BM. GH Response to Provocation and circulating IGF-I and IGFbinding protein-3 concentrations, the IGF-I Generation Test and Clinical Response to GH Therapy in Children with Beta-thalassemia. Eur J Endocrinol. 1998;138(4):394-400.
7. Soliman AT, ElZalabany MM, Mazloum Y, et al. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth. J Trop Pediatr. 1999;45(6):327-337.
8. El-Nanawy AA, el Azzouni OF, Soliman AT, Amer AE, Demian RS, El-Sayed HM. Prevalence of Hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr. 1995;41(6):341-343.
9. Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with ß-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82(10):637-640.
10. Geffner ME, Karlsson H. Use of recombinant human growth hormone in children with thalassemia. Horm Res. 2009;71(l):46-50.
11. Oerter KE, Kamp GA, Munson PJ, Nienhaus AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab. 1993;76:357-361.
12. Grundy RG, Wood KA, Savage MO, Evan JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child. 1994;74:128-132.
13. Bucuvalas JC, Cutfield W, Horn J, et al. Resistance to the growth promoting effects of growth hormone in children with chronic liver disease. J Pediatr. 1990;117:397-402.
14. Soliman AT, Nasr I, Thabet A, Rizk MM, El Matary W. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with b-thalassemia major. Metabolism. 2005;54:15-24.
15. Soliman AT, elZalabany MM, Ragab M, et al. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. J Trop Pediatr. 2000;46(2):79-85.
16. Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: Correlation with growth and hormonal data. Metabolism. 1998;47(5):541-548.
17. Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;16(Suppl. 2):259-266.
18. Saka N, Sükür M, Bundak R, Anak S, Neyzi O, Gedikoglu G. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 1995;8(3):181-186.
19. Constantoulakis M, Panagopoulos G, Augoustaki O. Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients. Clin Pediatr (Phila). 1975;14(4):355-368.
20. Kwan EYW, Lee ACW, Li AMC, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassemia major in Hong Kong. J Pediatr Child Health. 1995;31:83-87.
21. Shehadeh N, Hazani A, Rudolf MC, Peleg I, Benderly A, Hochberg Z Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand. 1990;79(8-9):790-795.
22. Spiliotis BE, Chrysis DC, Alexandrides TK, Georgopoulos N, Koromantzou EV, Beratis NG. IGF-I generation test as a potential marker of growth hormone neurosecretory dynamics in b-thalassemia. Program and Abstracts of the 10th International Congress of Endocrinology, San Francisco CA, USA, June 12-15, 1996;(Abstract P1-P127).
23. Argyropoulou MI, Kiortsis DN, Efremidis SC. MRI of the liver and the pituitary gland in patients with b-thalassemia major: Does hepatic siderosis predict pituitary iron deposition? Eur Radiol. 2003;13(1):12-16.
24. Argyropoulou MI, Metafratzi Z, Kiortsis DN, Bitsis S, Tsatsoulis A, Efremidis S. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR Am J Roentgenol. 2000;175(6):1567- 1569.
25. Au WY, Lam W, Chu W, et al. A cross-sectional MRI T2* study of pancreatic and pituitary hemosiderosis in 180 thalassemia major patients in Hong Kong. ASH Annual Meeting Abstracts. 2007;110(11):2771.
26. Chrysis DC, Spiliotis BE, Alexandrides TK, Makri M, Beratis NG. Growth hormone and insulin-like growth factor dynamics in thalassemia major. Program and Abstracts of the 77th Annual Meeting of the Endocrine Society, Washington DC, USA, June 14-17, 1995; (Abstract P1-175).
27. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P. Improvement of diagnostic criteria in growth hormone. insensitivity syndrome: Solutions and pitfalls. Acta Paediatrica. 1994;399(Suppl.):117-124.
28. Low LCK. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175-184.
29. Kwan EYW, Tam SCF, Cheung PT, Low LCK. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with b-thalassemia major. J Pediatr Endocrinol Metab. 2000;13:545-552.
30. Low LCK, Kwan EYW, Cheung PT. Final height of growth hormone treated non-GH deficient children with b-thalassemia major. Proceedings of the Endocrine Society 81st Annual Meeting, San Diego, California. June 12, 1999.
31. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003;88:3966-3972.
32. De Sanctis V, Stea S, Savarino1 L, et al. Osteochondrodystrophic lesions in chelated thalassemic patients: An histological analysis. Calcif Tissue Int. 2000;67(2):134-140. (Pubitemid 30616010)
33. Chand G, Chowdhury V, Manchanda A, Singh S. Deferiprone-induced arthropathy in thalassemia: MRI findings in a case. Indian J Radiol Imaging. 2009;19(2):155-157.
34. Theodoridis C, Ladis V, Papatheodorou A, et al. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab. 1998;11(Suppl. 3):835-844.
35. Soliman A, Adel A, Wagdy M, Al Ali M, ElMulla N. Calcium homeostasis in 40 adolescents with beta-thalassemia major: A case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev. 2008;6(Suppl. 1):146-149.
36. Arcasoy A, Canata D, Sinav B, et al. Serum zinc levels and zinc binding capacity in thalassemia. J Trace Elem Med Biol. 2001;15:85-87. HMC Document Delivery Bibliographic Links External Resolver [Context Link].
37. Arcasoy A, Çavdar A, Cin S, et al. Effects of zinc supplementation on linear growth in beta-thalassemia (A new approach). Am J Hematol. 1986;24(2):127-136.
38. Yesilipek MA, Hazar V, Yegin O. L-carnitine treatment in beta thalassemia major. Acta Haematol. 1998;100:33, 162-163